X4 Pharmaceuticals (XFOR) Total Current Liabilities (2018 - 2025)
Historic Total Current Liabilities for X4 Pharmaceuticals (XFOR) over the last 8 years, with Q3 2025 value amounting to $23.5 million.
- X4 Pharmaceuticals' Total Current Liabilities fell 1965.96% to $23.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.5 million, marking a year-over-year decrease of 1965.96%. This contributed to the annual value of $32.9 million for FY2024, which is 4380.63% up from last year.
- As of Q3 2025, X4 Pharmaceuticals' Total Current Liabilities stood at $23.5 million, which was down 1965.96% from $22.9 million recorded in Q2 2025.
- X4 Pharmaceuticals' Total Current Liabilities' 5-year high stood at $32.9 million during Q4 2024, with a 5-year trough of $13.1 million in Q2 2021.
- In the last 5 years, X4 Pharmaceuticals' Total Current Liabilities had a median value of $22.9 million in 2023 and averaged $22.1 million.
- In the last 5 years, X4 Pharmaceuticals' Total Current Liabilities soared by 11699.67% in 2022 and then crashed by 2078.06% in 2025.
- X4 Pharmaceuticals' Total Current Liabilities (Quarter) stood at $14.0 million in 2021, then soared by 59.2% to $22.3 million in 2022, then increased by 2.41% to $22.9 million in 2023, then soared by 43.81% to $32.9 million in 2024, then fell by 28.5% to $23.5 million in 2025.
- Its last three reported values are $23.5 million in Q3 2025, $22.9 million for Q2 2025, and $25.9 million during Q1 2025.